Mechanisms by Which Antibiotics Promote Dissemination of Resistant Pneumococci in Human Populations
Open Access
- 30 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 163 (2) , 160-170
- https://doi.org/10.1093/aje/kwj021
Abstract
Mechanisms by which antimicrobials contribute to dissemination of pneumococcal resistance are incompletely characterized. A serial cross-sectional study of nasopharyngeal pneumococcal carriage in healthy, home-living children ≤6 years of age was conducted in four rural communities—two in Utah (1998–2003) and two in Idaho (2002–2003). Prevalence odds ratios for carriage of resistant pneumococci (ORres) and of susceptible pneumococci (ORsus) were estimated. Dynamic transmission models were developed to facilitate a mechanistic interpretation of ORres and ORsus and to compare the population impact of distinct antimicrobial classes. A total of 5,667 cultures were obtained; 25% of the cultures were positive, and 29% of isolates exhibited reduced susceptibility to penicillin. The adjusted ORres for recent individual and sibling cephalosporin use was 2.2 (95% confidence interval: 1.4, 3.4) and 1.8 (95% confidence interval: 1.0, 3.3), respectively. Neither individual nor sibling penicillin use was associated with increased ORres. Rather, recent use of penicillins was associated with decreased carriage of susceptible pneumococci (ORsus = 0.2, 95% confidence interval: 0.1, 0.3). In simulations, both types of effects promoted dissemination of resistant pneumococci at the population level. Findings show that oral cephalosporins enhance the risk of acquiring resistant pneumococci. Penicillins accelerate clearance of susceptible strains. The effect of penicillins in increasing resistance is shared equally by treated and untreated members of the population.Keywords
This publication has 50 references indexed in Scilit:
- Statistical and Substantive Inferences in Public Health: Issues in the Application of Multilevel ModelsAnnual Review of Public Health, 2004
- Factors Associated with Relative Rates of Antimicrobial Resistance amongStreptococcus pneumoniaein the United States: Results from the TRUST Surveillance Program (1998–2002)Clinical Infectious Diseases, 2003
- Antimicrobial Use and Antimicrobial Resistance: A Population PerspectiveEmerging Infectious Diseases, 2002
- Measuring and Interpreting Associations between Antibiotic Use and Penicillin Resistance in Streptococcus pneumoniaeClinical Infectious Diseases, 2001
- Active Bacterial Core Surveillance of the Emerging Infections Program NetworkEmerging Infectious Diseases, 2001
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000
- Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in AustraliaThe Medical Journal of Australia, 1999
- Extending the simple linear regression model to account for correlated responses: An introduction to generalized estimating equations and multi-level mixed modellingStatistics in Medicine, 1998
- Antibiotic Resistance in Streptococcus pneumoniaeClinical Infectious Diseases, 1997
- Pneumococcal Resistance to β-Lactam Antibiotics: A Global Geographic OverviewMicrobial Drug Resistance, 1995